ACE Inhibitor Slows or Reverses Renal Disease in Diabetics
|
By HospiMedica staff writers Posted on 12 Feb 2002 |
|
A new therapy that uses an existing angiotensin converting enzyme (ACE) inhibitor has been shown to delay the progression of kidney disease caused by type 2 diabetes. If the therapy is provided early enough, kidney disease can be reversed altogether.
The results are based on data from a three-year study conducted by GenoMed, Inc. (St. Louis, MO, USA). Dr. David Moskowitz, chairman and chief medical officer of GenoMed, has discovered that ACE is associated with around 40 common serious diseases such as kidney disease and other complications of type 2 diabetes. With the new treatment, the time to kidney dialysis for African-American men increased from 3.3 years to an average of 9.3 years. For Caucasian men, the time was extended from 2.7 years to 4.0 years. When patients were treated before their serum creatinine reached 2 mg per deciliter, the disease was reversed.
According to Dr. Moskowitz, using existing drugs for new clinical indications is often the quickest and least-expensive way to improve a patient's condition. GenoMed is dedicated to identifying additional disease-associated genes, working on new treatments using existing drugs, and developing new drugs specifically designed against disease-causing genes.
"I'm excited because our initial data are so promising,” said Dr. Moskowitz. "The challenge now is to reach healthcare companies and large employers who can capitalize on the clinical and financial outcomes for patients.”
Related Links:
GenoMed
The results are based on data from a three-year study conducted by GenoMed, Inc. (St. Louis, MO, USA). Dr. David Moskowitz, chairman and chief medical officer of GenoMed, has discovered that ACE is associated with around 40 common serious diseases such as kidney disease and other complications of type 2 diabetes. With the new treatment, the time to kidney dialysis for African-American men increased from 3.3 years to an average of 9.3 years. For Caucasian men, the time was extended from 2.7 years to 4.0 years. When patients were treated before their serum creatinine reached 2 mg per deciliter, the disease was reversed.
According to Dr. Moskowitz, using existing drugs for new clinical indications is often the quickest and least-expensive way to improve a patient's condition. GenoMed is dedicated to identifying additional disease-associated genes, working on new treatments using existing drugs, and developing new drugs specifically designed against disease-causing genes.
"I'm excited because our initial data are so promising,” said Dr. Moskowitz. "The challenge now is to reach healthcare companies and large employers who can capitalize on the clinical and financial outcomes for patients.”
Related Links:
GenoMed
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Auditory Evoked Potential Device
Bio-logic NavPRO ONE
New
Surgical Positioning Accessory
Lateral Support Curved Short (10-360)
Latest Patient Care News
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
Channels
Critical Care
view channel
Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more
Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
Multiphoton microscopy has become an invaluable tool in neuroscience, allowing researchers to observe brain activity in real time with high-resolution imaging. A crucial aspect of many multiphoton microscopy... Read more
Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read more
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read more
Health IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more
